MD Anderson expert highlights impact of WHO’s updated AML diagnostic criteria on patient care
read at onclive ↗Positive
Dr Sanam Loghavi, an associate professor and medical director at MD Anderson Cancer Center, discussed the recently revised WHO diagnostic criteria for acute myeloid leukemia.
She emphasized that a precise diagnosis is the foundation for all subsequent treatment choices, and aligning trial eligibility with the new criteria is essential for enrolling patients in appropriate studies.
The updates are expected to influence how clinicians classify AML cases, select therapies, and communicate across oncology and pathology teams in everyday practice.
source
This writeup was produced by pharmadog from original reporting by onclive.
Original headline: “Dr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical Practice”
read at onclive ↗1,718 words · retrieved May 13
comments(0)
5-min edit window · permanent after that